People In Brief
This article was originally published in The Gray Sheet
Executive Summary
Angeion CEO
You may also be interested in...
People In Brief
The latest moves by movers and shakers in the medical device and diagnostics industries
People In Brief
CEO, CFO resign over trading flap
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.